Vistusertib Active Not Recruiting Phase 2 Trials for Meningiomas Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03071874Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas